Science Current Events | Science News | Brightsurf.com
 

Cancer Vaccine Current Events | Cancer Vaccine News | 8

Sort By: Page Views | Date

New discovery gives tuberculosis vaccine a shot in the arm
A new article appearing in the March 2009 issue of the Journal of Leukocyte Biology may lead to improvements in the efficacy of the current tuberculosis vaccine.   view more (2009-02-27)

NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
Most vaccines that protect against viruses generate infection-fighting proteins called antibodies that either block infection or help eliminate the virus before it can cause disease.   view more (2009-06-15)

MMR vaccine linked to bleeding disorder
The measles, mumps, and rubella vaccine is linked to a bleeding disorder, called idiopathic thrombocytopenic purpura (ITP) in children, finds a study in Archives of Disease in Childhood. The disorder is caused by a shortage of platelets, the cells that give blood its "stickiness," and is characterised by bleeding under the skin. Around one in... view more... (2001-02-20)

A missed shot: The failure of HPV vaccination state requirements
In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues.   view more (2007-11-02)

Flu shot protects kids -- even during years with a bad vaccine match
Children who receive all recommended flu vaccine appear to be less likely to catch the respiratory virus that the CDC estimates hospitalizes 20,000 children every year.   view more (2008-11-03)

Vaccine prevents prion disease in mice
An oral vaccine can prevent mice from developing a brain disease similar to mad cow disease.   view more (2007-05-04)

Vaccine to cope with viral diversity in HIV
The ability of HIV-1 to develop high levels of genetic diversity and acquire mutations to escape immune pressures contributes to our difficulties in producing a vaccine.   view more (2007-04-27)

A simplified method of giving rabies vaccine
A simplified economical method of giving rabies vaccine is just as effective as the expensive standard vaccine regimen at stimulating anti-rabies antibodies.   view more (2008-04-23)

St. Jude test of bird flu vaccine proves successful
A commercially developed vaccine has successfully protected mice and ferrets against a highly lethal avian influenza virus, according to the investigator who led the study at St. Jude Children's Research Hospital.   view more (2006-05-03)

Vaccine improves event-free survival for leukemia patients
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.   view more (2007-12-10)

Cervical cancer prevention should focus on vaccinating adolescent girls
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by... view more... (2008-08-21)

Whooping cough-making a comeback?
Whooping cough (pertussis) is most easily diagnosed in young children because they develop a characteristic cough-paroxysms of coughing followed by a long inspiration that makes a whooping sound.   view more (2006-02-14)

Nosespray vaccine using aloe vera has exciting potential, researcher says
Researchers at Texas A&M University are participating in developing a medicine that is worth sneezing about: a treatment for influenza that forms a jelly when sprayed into the nose.   view more (2007-09-26)

Novel tuberculosis vaccine in Germany in clinical phase
For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany.   view more (2008-09-12)

Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
Effector T cells (Teff cells) are involved in activating and directing other immune cells, while regulatory T cells (Tregs) act to curb the over-aggressive responses of the T cell population.   view more (2006-06-16)

Flu vaccine given to women during pregnancy keeps infants out of the hospital
Infants born to women who received influenza vaccine during pregnancy were hospitalized at a lower rate than infants born to unvaccinated mothers.   view more (2009-11-03)

Progress made in HIV vaccine development
Researchers have successfully tested two candidate vaccines that may eventually be used together to confer immunity against HIV infection. Their findings are published in the December 15 issue of The Journal of Infectious Diseases, now available online.   view more (2006-11-13)

Higher anaphylaxis rates after HPV vaccination: CMAJ study
The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher - 5 to 20 fold - than that identified in comparable school-based vaccination programs.   view more (2008-09-02)

Most would refuse emergency use H1N1 vaccine or additive
A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study.   view more (2009-09-30)

Vaccine/antibody therapy effective, milder side effects in melanoma and ovarian cancer
One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system's attack on cancer cells is that many patients whose tumors recede in response to the treatment also experience serious inflammatory problems, such as severe diarrhea and rashes.   view more (2008-02-19)
Sort By: Page Views | Date
© 2009 BrightSurf.com